The newly formed nurses unions at UPMC Magee-Womens Hospital will get to flex their power at the bargaining table for the ...

Every January, gyms overflow with new members determined to finally prioritize their health. By March, the crowds thin, ...

More than half a dozen major drugmakers are participating in the Trump administration's speedier review program for new medicines, yet other leading pharmaceutical companies are hesitating over what ...

Discover why sleep is more powerful than you think—and how a lack of it can quietly impact everything from your mood to long‑term brain health.

Cervical lymphadenopathy presents a shared anatomic challenge for clinicians, yet it serves as the divergent starting point ...

Two new studies from the Centers for Disease Control and Prevention show wastewater monitoring of measles can flag measles ...

Two AI chat tools, including Microsoft Copilot, are in use at the VA but have not been reviewed by patient safety offices.

The U.S. Food and Drug Administration has delayed reviews of two drugs chosen for the Trump administration's new fast-track ...

Christopher Shaffrey, MD, has seen spine care evolve through rapid innovation.  But as outcomes and complication rates face greater scrutiny, the chief of the spine division at Durham, N.C.-based Duke ...

Vera Therapeutics, Inc. (NASDAQ:VERA) is among the 14 best booming stocks to buy right now. On January 7, the company ...

Revenue cycle leaders 8217 focus on automation, AI, and leadership succession to improve efficiency and cash flow in 2026.

Target action dates for drugs sponsored by Sanofi, Boehringer Ingelheim and Disc Medicine have also been pushed back despite ...